
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
Showing 26-50 of 46 citing articles:
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
A Practical Guide for the Assay-Dependent Characterisation of Irreversible Inhibitors
Lavleen Mader, Jessica E. Borean, Jeffrey W. Keillor
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Lavleen Mader, Jessica E. Borean, Jeffrey W. Keillor
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
N-Acyl-N-alkyl/aryl Sulfonamide Chemistry Assisted by Proximity for Modification and Covalent Inhibition of Endogenous Proteins in Living Systems
Tomonori Tamura, Itaru Hamachi
Accounts of Chemical Research (2024)
Closed Access | Times Cited: 2
Tomonori Tamura, Itaru Hamachi
Accounts of Chemical Research (2024)
Closed Access | Times Cited: 2
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
(2024)
Open Access | Times Cited: 1
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
(2024)
Open Access | Times Cited: 1
Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations
Tomasz M. Wróbel, Damian Bartuzi, Agnieszka A. Kaczor
Journal of Chemical Information and Modeling (2024)
Open Access | Times Cited: 1
Tomasz M. Wróbel, Damian Bartuzi, Agnieszka A. Kaczor
Journal of Chemical Information and Modeling (2024)
Open Access | Times Cited: 1
Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?
Yasir S. Raouf, Carlos Moreno–Yruela
JACS Au (2024) Vol. 4, Iss. 11, pp. 4148-4161
Open Access | Times Cited: 1
Yasir S. Raouf, Carlos Moreno–Yruela
JACS Au (2024) Vol. 4, Iss. 11, pp. 4148-4161
Open Access | Times Cited: 1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? – A Teacher's Perspective
Philipp Klahn
ChemMedChem (2024)
Open Access | Times Cited: 1
Philipp Klahn
ChemMedChem (2024)
Open Access | Times Cited: 1
Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase
Jung-Chun Chu, Keng‐Chang Tsai, Tingyu Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117169-117169
Closed Access | Times Cited: 1
Jung-Chun Chu, Keng‐Chang Tsai, Tingyu Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117169-117169
Closed Access | Times Cited: 1
Metabolism of new drug modalities research advances – 2023 year in review
Bin Ma, Upendra A. Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews (2024), pp. 1-24
Closed Access
Bin Ma, Upendra A. Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews (2024), pp. 1-24
Closed Access
Functional implications of unusual NOS and SONOS covalent linkages found in proteins
Matthew D. Lloyd, Kyle S. Gregory, K. Ravi Acharya
Chemical Communications (2024) Vol. 60, Iss. 71, pp. 9463-9471
Open Access
Matthew D. Lloyd, Kyle S. Gregory, K. Ravi Acharya
Chemical Communications (2024) Vol. 60, Iss. 71, pp. 9463-9471
Open Access
Replacement of nitro function by free boronic acid in non-steroidal anti-androgens
Petr Šlechta, Roman Viták, Pavel Bárta, et al.
RSC Medicinal Chemistry (2024)
Open Access
Petr Šlechta, Roman Viták, Pavel Bárta, et al.
RSC Medicinal Chemistry (2024)
Open Access
Utilizing Artificial Intelligence for Precision Exploration of N Protein Targeting Phenanthridine SARS-CoV-2 Inhibitors: A Novel Approach
Zheng-Rui Xiang, Shi-rui Fan, Juan Ren, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116885-116885
Closed Access
Zheng-Rui Xiang, Shi-rui Fan, Juan Ren, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116885-116885
Closed Access
Chem(Pro)2: the atlas of chemoproteomic probes labelling human proteins
Songsen Fu, Zhe Chen, Zhiming Luo, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1651-D1662
Open Access
Songsen Fu, Zhe Chen, Zhiming Luo, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1651-D1662
Open Access
A Platform of ADAPTive Scaffolds: Development of CDR-H3 β-Hairpin Mimics into Covalent Inhibitors of the PD1/PDL1 Immune Checkpoint.
Sarah Naylon, Alexis D. Richaud, Guangkuan Zhao, et al.
RSC Chemical Biology (2024)
Open Access
Sarah Naylon, Alexis D. Richaud, Guangkuan Zhao, et al.
RSC Chemical Biology (2024)
Open Access
ARCaDia: Single-round screening of a DNA-type targeted covalent binder possessing a latent warhead
Masumi Taki, Masayasu Kuwahara, Chaohui Li, et al.
Chemical Communications (2024)
Open Access
Masumi Taki, Masayasu Kuwahara, Chaohui Li, et al.
Chemical Communications (2024)
Open Access
Global Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Mengya Zhou, Shengrong Li, Yi Tan, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Mengya Zhou, Shengrong Li, Yi Tan, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Global Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Mengya Zhou, Shengrong Li, Yi Jiun Tan, et al.
Angewandte Chemie (2024)
Closed Access
Mengya Zhou, Shengrong Li, Yi Jiun Tan, et al.
Angewandte Chemie (2024)
Closed Access
Tilting the Scales toward EGFR Mutant Selectivity: Expanding the Scope of Bivalent “Type V” Kinase Inhibitors
Florian Wittlinger, Surbhi P. Chitnis, Calvin D. Pham, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 23, pp. 21438-21469
Closed Access
Florian Wittlinger, Surbhi P. Chitnis, Calvin D. Pham, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 23, pp. 21438-21469
Closed Access
Probing the Protein Kinases' Cysteinome by Covalent Fragments
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Probing the Protein Kinases' Cysteinome by Covalent Fragments
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie (2024)
Closed Access
Guiqun Wang, Nico J. Seidler, Sandra Röhm, et al.
Angewandte Chemie (2024)
Closed Access
Innovative design and potential applications of covalent strategy in drug discovery
Tianxi Tang, Jiaxiang Luo, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117202-117202
Closed Access
Tianxi Tang, Jiaxiang Luo, Dan Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117202-117202
Closed Access